MNPR Market Cap History Table | ||||||||||||||||||||||||||||||||||||
Also see: MNPR Shares Outstanding History and MNPR YTD Return |
MNPR Market Cap History Table | ||||||||||||||||||||||||||||||||||||
Also see: MNPR Shares Outstanding History and MNPR YTD Return |
MNPR Market Cap History Chart | |||||||||||||||||||||||||||||||||||||
-50.44% CAGR Mouse over chart for data details
|
MNPR Stock Price Chart |
About Monopar Therapeutics Inc |
Monopar Therapeutics is a biopharmaceutical company focused on developing proprietary therapeutics for cancer patients. Co.'s compounds in development: Validive®, a Phase 2b/3 clinical stage, mucoadhesive buccal tablet for the prevention of radiation induced severe oral mucositis in oropharyngeal cancer patients; camsirubicin, a Phase 1b clinical stage analog of doxorubicin engineered specifically to retain anticancer activity while minimizing toxic effects on the heart; MNPR-101, a preclinical stage uPAR-targeted antibody being developed as a radioimmunotherapeutic and companion diagnostic for cancers and COVID-19; and an early stage camsirubicin analog, MNPR-202, for various cancers. We show 17 historical shares outstanding datapoints in our MNPR shares outstanding history coverage, used to compute MNPR market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing MNPR market cap history over the course of time is important for investors interested in comparing MNPR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of MNPR versus a peer is one thing; comparing MNPR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like MNPR can fluctuate over the course of history. With this page we aim to empower investors researching MNPR by allowing them to research the MNPR market cap history. |
MNPR Current Stock Quote |
Free MNPR Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
MNPR Share Performance |
Market Cap Peers |
Monopar Therapeutics (MNPR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
MNTA Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.